AzTrials
AzTrials

Low Vision in ChildrenNCT07703449

Research and Development of Reading Visual Aids for Low-Vision Individuals Based on Virtual Reality Technology

A study testing VR-Based Intelligent Reading Aid and Natural Vision Reading (No Assistive Device) in people with Low Vision in Children, run by Beijing Tongren Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Low vision substantially impairs reading ability and educational participation in adolescents. Existing assistive technologies, including optical magnifiers and electronic visual aids, are often limited by fragmented system architectures and insufficient support for multimodal cognitive processing. Read more about this study

Who is it for?
Ages 9 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Low Vision in Children
What is being tested?
VR-Based Intelligent Reading Aid and Natural Vision Reading (No Assistive Device)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteChina
Study dates
15 Jun 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Aged 9-17 years
  • Clinically diagnosed with visual impairment, meeting the inclusion criteria for low vision or severe visual impairment
  • Sufficient basic reading ability to complete the experimental tasks
  • Written informed consent obtained from all participants and their legal guardians prior to participation

Who cannot join

  • Any current or previous organic ocular disease (such as keratitis, glaucoma, or retinal detachment)
  • Previous ophthalmic surgery (including refractive surgery or vitreoretinal surgery)
  • Systemic or psychiatric disorders that could affect study participation
  • Inability or unwillingness to complete the examination procedures
  • Functional Evaluation Cohort:
  • Systemic or psychiatric disorders affecting participation
  • Inability or unwillingness to complete the examination procedures Functional Evaluation Cohort

Trial locations and contacts

1 site in 1 country.

China1 site
  • Specialized School for Visually Impaired Students in Guangdong Province

    Guangzhou, Guangdong, 510060

Other trials in China

About this study

Official title: Illuminate Children's Reading World: Research and Development of Virtual Reality Reading Aids for Low-Vision Populations

Low vision substantially impairs reading ability and educational participation in adolescents. Existing assistive technologies, including optical magnifiers and electronic visual aids, are often limited by fragmented system architectures and insufficient support for multimodal cognitive processing.

This study aimed to develop and evaluate a virtual reality (VR)-based intelligent reading aid integrating image enhancement, optical character recognition (OCR), text-to-speech (TTS), and large language model (LLM)-based semantic summarization for low-vision users.

Being tested
VR-Based Intelligent Reading Aid, Natural Vision Reading (No Assistive Device)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR-Based Intelligent Reading AidDevice

    Intervention Description: Participants use the VR head-mounted intelligent reading aid to complete the same standardized reading tasks. The device integrates image enhancement, OCR, text-to-speech (TTS) and LLM-based semantic summarization. The test luminance is set at 400 nit (maximum recommended brightness). Each task contains 100 Chinese characters.

    Duration:Single session, approximately 5 minutes

  • Natural Vision Reading (No Assistive Device)Device

    Participants complete reading tasks with natural vision, without using any assistive device.

Study groups in NCT07703449
Study groupRoleWhat they receive
Baseline: Unaided ReadingExperimentalArm Name:Unaided Reading (Baseline) Arm Type:Active Comparator Intervention Type:Device Intervention Name:Natural Vision Reading (No Assistive Device) Intervention Description: Participants complete standardized Chinese reading tasks relying on natural vision without any visual aid. Each task contains 100 Chinese characters. Reading performance and user satisfaction are evaluated.
Receives: Device: VR-Based Intelligent Reading Aid
Experimental: VR-Assisted ReadingExperimentalArm Name:VR-Based Intelligent Reading Aid Arm Type:Experimental Intervention Type:Device Intervention Name:VR-Based Multimodal Intelligent Reading Aid (Langshiqing Low-Vision Device) Intervention Description: Participants use the VR head-mounted intelligent reading aid to complete the same standardized reading tasks. The device integrates image enhancement, OCR, text-to-speech (TTS) and LLM-based semantic summarization. The test luminance is set at 400 nit (maximum recommended brightness). Each task contains 100 Chinese characters. Duration:Single session, approximately 5 minutes
Receives: Device: Natural Vision Reading (No Assistive Device)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Phoria

    Variation of ocular phoria before and after single-session VR intelligent reading aid use, to evaluate the impact of near-eye VR optical system on adult eye position stability.

    Measured: within 10 minutes after all reading tasks

  2. Reading Completion Time

    Time to finish standardized 100-character Chinese reading tasks (unit: second). Compare results between unaided and VR-assisted conditions.

    Measured: within 10 minutes after all reading tasks

Secondary outcomes (6)
  1. Tear Break-Up Time (TBUT)

    Change in tear break-up time before and after VR device use for assessment of ocular surface dryness in adult participants.

    Measured: within 10 minutes after all reading tasks

  2. Accommodative Function

    Alteration of eye accommodative function after using the VR reading aid among adult subjects.

    Measured: within 10 minutes after all reading tasks

  3. Simulator Sickness Questionnaire (SSQ)

    Scale Description:The SSQ is a self-report questionnaire that assesses VR-related simulator sickness. Each item is rated on a 4-point scale: None (0), Slight (1), Moderate (2), and Severe (3). Through weighted calculations, four scores are derived: Nausea-related subscore (N), Oculomotor-related subscore (O), Disorientation-related subscore (D), and Total Score (TS).

    Minimum and Maximum Values:

    • ndividual items: 0 (None) to 3 (Severe)
    • Total Score (TS): 0 to 235.62 (based on standard weighted scoring)
    • Nausea subscore (N): 0 to 200.34
    • Oculomotor subscore (O): 0 to 200.34
    • Disorientation subscore (D): 0 to 292.32 Interpretation:Higher scores indicate worse outcomes (more severe simulator sickness/cybersickness).

    Measured: within 10 minutes after all reading tasks

  4. Best-Corrected Visual Acuity (BCVA)

    Change in best-corrected visual acuity before and after VR reading session for adult low-vision users.

    Measured: within 10 minutes after all reading tasks

  5. Intraocular Pressure (IOP)

    Fluctuation of intraocular pressure pre and post VR device reading task in adult participants.

    Measured: within 10 minutes after all reading tasks

  6. User Satisfaction Score

    100-point satisfaction scale. VR group includes four sub-items: magnification, text-to-speech, OCR and AI summarization (25 points each).

    Measured: within 10 minutes after all reading tasks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study start15 Jun 2024
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07703449
Sponsor's protocol ID
2024LSPJ164
Status last verified
Jun 2026
First submitted
15 Jun 2026
Last updated
14 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR-Based Intelligent Reading Aid and Natural Vision Reading (No Assistive Device) in people with Low Vision in Children, run by Beijing Tongren Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Phoria (time frame: within 10 minutes after all reading tasks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in